PureTech Health (PRTC) Total Current Liabilities (2019 - 2025)
PureTech Health (PRTC) reported Total Current Liabilities of $46.3 million for Q4 2025, up 11.89% year-over-year from $41.4 million in Q4 2024, and up 14.13% on a QoQ basis from $40.6 million in Q2 2025.
PureTech Health (PRTC) has 6 years of Total Current Liabilities data on file, last reported at $46.3 million in Q4 2025.
- Quarterly Total Current Liabilities rose 11.89% year-over-year to $46.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $46.3 million (up 11.89% YoY) and the FY2025 annual result came in at $46.3 million, up 11.89% from the prior year.
- Total Current Liabilities rose to $46.3 million in Q4 2025 per PRTC's latest filing, from $40.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $226.1 million in Q4 2021 and bottomed at $40.6 million in Q2 2025.
- The 4-year median for Total Current Liabilities is $46.3 million (2025), against an average of $90.3 million.
- The widest annual swing landed in 2021, when Total Current Liabilities climbed 24.99%; it then slumped 57.16% in 2022.
- Tracing PRTC's Total Current Liabilities over 4 years: stood at $226.1 million in 2021, then tumbled by 57.16% to $96.9 million in 2022, then tumbled by 57.28% to $41.4 million in 2024, then increased by 11.89% to $46.3 million in 2025.
- Per Business Quant, the three latest PRTC Total Current Liabilities figures stand at $46.3 million (Q4 2025), $40.6 million (Q2 2025), and $41.4 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 5.11 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.35 Bn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 46.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.31 Mn |
| Jun 30, 2025 | 40.58 Mn |
| Dec 31, 2024 | 41.39 Mn |
| Dec 31, 2022 | 96.89 Mn |
| Dec 31, 2021 | 226.14 Mn |
| Dec 31, 2020 | 180.92 Mn |
| Dec 31, 2019 | 139.20 Mn |